Approval. Development and Research expenditures for the quarter ended March 31, 2012, were $16.1 million in comparison to $18.2 million for the quarter ended March 31, 2011. The decrease was due to reduced consulting costs as mainly a result of the completion of the filing of our New Drug Application with the U.S. Food and Drug Administration in-may 2011 and reduced personnel-related costs. This was offset by ongoing medical partially trial activity for the company’s Stage 3b trial, and a continuing Phase 2 study in Pure Crimson Cell Aplasia patients. Selling, general and administrative expenses for the quarter ended March 31, 2012, were $15.6 million in comparison to $8.2 million for the quarter ended March 31, 2011.Additionally it is responsible for 500 bowel cancers in men , and is just about the reason behind 400 bowel cancers in women . Overall, researchers attribute 5 per cent of cancers to long-term alcohol consumption. But proof its association with common [cancers] like breasts and bowel makes the population impact much larger. If they can keep within the NHMRC suggestions, their risk would be very low. Cancer Council guidelines condition there is no safe level of alcohol consumption, and abstaining altogether is the only way to eliminate the chance of developing certain cancers.